"Generic Entry and the Pricing of Pharmaceuticals"
24 Pages Posted: 19 Jun 2000 Last revised: 3 Jul 2022
Date Written: October 1995
During the 1980s the share of prescriptions sold by retail pharmacies that was accounted for by generic products roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 drugs that lost patent protection during the early to mid-1980s. Our results provide strong evidence that brand-name prices increase after entry and are accompanied by large price decreases in the price of generic drugs.
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Higher Prices from Entry: Pricing of Brand-Name Drugs
By Jeffrey M. Perloff, Valerie Y. Suslow, ...
The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry
By Ernst R. Berndt, Linda Tm Bui, ...
Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
By Ernst R. Berndt, Robert S. Pindyck, ...
Pricing, Patent Loss and the Market for Pharmaceuticals
Generic Drug Industry Dynamics
By David Reiffen and Michael R. Ward
Hedonic Analysis of Arthritis Drugs
By Iain M. Cockburn and Aslam H. Anis
Longer Patents for Increased Generic Competition: The Waxman-Hatch Act after One Decade
By Henry G. Grabowski and John M. Vernon
The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the Us Pharmaceuticals Industry